Due to the Government’s commitment to guarantee timely access to vaccines against COVID-19, the president of the National Emergency Commission (CNE), Alexander Solís, and the representatives of the companies Pfizer and BioNTech signed a manufacturing and supply contract of the COVID-19 vaccine.
Costa Rica will receive three million seventy-five doses (3,000,075), so it will have coverage to grant two applications to one and a half million people.
The deliveries would be made throughout the four quarters of 2021 and the contract will be in force from this December 1 until all the agreed doses are delivered.
“Our priority and primary commitment is to protect the health and life of citizens against the pandemic, so very early we made the decision to negotiate with Pfizer and BioNTech, as well as with other companies and mechanisms, to guarantee us early and timely access to vaccines, and we are using all the means at our disposal to achieve this, ”said the President of the Republic, Carlos Alvarado.
For his part, Alexander Solís pointed out that “an inter-institutional work is being carried out that allows not only to have the first doses of vaccines in the shortest possible time, but also to supply all the logistical requirements that the vaccination strategy entails” and added that it is It is very satisfying to have the expeditious mechanisms that allow addressing the protection needs of the most vulnerable population in the face of COVID-19 in record time.
The work of the National Commission for Vaccination and Epidemiology has achieved Costa Rica’s adherence to the COVAX-Facility mechanism, which contemplates a population coverage of just over one million people, as well as the agreement with AstraZeneca to supply one million doses of its candidate vaccine against COVID-19, developed in conjunction with the University of Oxford.
This signature represents the legal consolidation of the agreement between the country and the companies announced on October 1.